Singapore · 
Who invested in Allozymes?
Allozymes's investors include SOSV, Entrepreneur First, Seventure Partners and Transpose Platform Management.
Singapore · Series A startup
Who invested in Allozymes
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $15MAug 2023
- Investors
- 4
The rounds
- Aug 2023
Founders and team
From Allozymes's own website: 2 founders, 6 on the team.
Peyman SalehianChief Executive Officer, Co-Founder
Akbar VahidiChief Technical Officer, Co-Founder
- Andreas ReindlChief Operating Officer
- Audrey RobicBusiness Development Director
- Dickson ThianBoard Member
- Henri NajadeBoard Member
- Oxana KukhanevaBoard Member
- Patrick Tan Say HwaSenior Microfluidics Scientist
Everyone who backed them
Transpose Platform ManagementVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Allozymes as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Allozymes
How much has Allozymes raised?
Allozymes has raised $15M across 1 round since 2023.
When did Allozymes last raise?
Allozymes's most recent round was a Series A of $15M in Aug 2023.
What was Allozymes's biggest round?
Its most recent round, $15M in Aug 2023, is also its largest on record.
Who backed Allozymes first?
Allozymes's first round on record, in Aug 2023, was backed by SOSV, Entrepreneur First and Seventure Partners and 1 others.
What stage is Allozymes at?
Allozymes's latest named round is a Series A, in Aug 2023.
Where is Allozymes based?
Allozymes is based in Singapore.
Companies like Allozymes
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.